Join to View Full Profile
NE Pacific St# 1959Seattle, WA 98195
Phone+1 206-288-1000
Fax+1 206-606-1025
Dr. Kiem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Ulm Faculty of MedicineClass of 1987, MD
University of WashingtonFellowship, Medical Oncology
Certifications & Licensure
WA State Medical License 1993 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2005
Clinical Trials
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation Start of enrollment: 2003 Jun 01
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia Start of enrollment: 2000 Jan 01
- Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia Start of enrollment: 1998 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Author Correction: Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells.Dorsa Toghani, Sanika Gupte, Sharon Zeng, Elmir Mahammadov, Edie I Crosse
Nature Aging. 2025-02-20 - Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates.Nicholas E Petty, Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert
Blood Advances. 2025-02-10 - Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells.Dorsa Toghani, Sanika Gupte, Sharon Zeng, Elmir Mahammadov, Edie I Crosse
Nature Aging. 2025-01-29
Abstracts/Posters
- Fully Closed, Large-Scale, and Clinical Grade Cell Sorting of Hematopoietic Stem Cell (HSC)-Enriched CD90+ Cells for Transplantation and Gene TherapyHans-Peter Kiem, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival after Repeat Infusions of CD19 CAR-T CellsClinically Relevant AbstractHans-Peter Kiem, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical OutcomesHans-Peter Kiem, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Non-Genotoxic Conditioning Efficiently Depletes Host Hematopoietic Stem Cells and Facilitates Robust Multi-Lineage Engraftment in a Mouse Model of Fanconi Anemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Factors Impacting Progression-Free Survival after CD19-Specific CAR-T Cell Therapy for Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Engineering Resistance to CD33-Targeted Immunotherapy in Normal Hematopoiesis By CRISPR/Cas9-Deletion of CD33 Exon 22018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022- Testing Cord Blood Transplants as a Cure for Leukemia — and HIVMarch 10th, 2022
- Relying on an Ultra-Rare Variant, David Liu Unveils a New Approach to Editing Sickle CellJune 2nd, 2021
- Join now to see all
Grant Support
- In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cureUNIVERSITY OF WASHINGTON2023–2027
- In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cureUNIVERSITY OF WASHINGTON2023–2027
- Novel hematopoietic stem cell engineering and transplantation approaches for HIV cureUNIVERSITY OF SOUTHERN CALIFORNIA2020–2025
- Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and EditingFRED HUTCHINSON CANCER CENTER2020–2025
- Endothelial cell transplantation for multi-organ repair to counter radiation injuryWEILL MEDICAL COLL OF CORNELL UNIV2018–2025
- Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathyFRED HUTCHINSON CANCER CENTER2017–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
